[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET.
暂无分享,去创建一个
J van den Hoff | W Burchert | G J Meyer | H G Wolpers | J. van den Hoff | W. Burchert | H. Wolpers | G. Meyer | W. Knapp | H Fricke | H. Fricke | W H Knapp | D. Otto | E. Weckesser | A. Börner | A R Börner | G Kühnel | D Otto | E Weckesser | G. Kühnel
[1] M E Phelps,et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.
[2] N. Sadato,et al. Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states , 1992, Annals of nuclear medicine.
[3] H. Schelbert,et al. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. , 1993, The American journal of cardiology.
[4] B E Sobel,et al. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. , 1987, Circulation.
[5] D. Kuhl,et al. Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] M E Phelps,et al. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] S S Gambhir,et al. Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging , 1992, Circulation.
[8] William H. Press,et al. Numerical recipes in C , 2002 .
[9] D. Kuhl,et al. N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.
[10] M. Walsh,et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] M. Phelps,et al. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] J. van den Hoff,et al. A kinetic model for cardiac PET with [1-carbon-11]-acetate. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] G. Hutchins,et al. Metabolic fate of [13N]ammonia in human and canine blood. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] M. Phelps,et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. , 1993, Circulation.
[15] S. Bergmann,et al. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] M. Phelps,et al. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] J. van den Hoff,et al. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction. , 1997, Circulation.
[18] R. Gropler,et al. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] M. Phelps,et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] A. Luxen,et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. , 1989, Circulation.
[21] M. Schwaiger,et al. Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. , 1992, American heart journal.
[22] H R Schelbert,et al. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. , 1990, Circulation.
[23] E. Topol,et al. Use of carbon-11 acetate and dynamic positron emission tomography to assess regional myocardial oxygen consumption in patients with acute myocardial infarction receiving thrombolysis or coronary angioplasty. , 1993, The American journal of cardiology.
[24] E. M. Renkin. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. , 1959, The American journal of physiology.
[25] G. Hutchins,et al. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] C. Crone,et al. THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.
[27] S. Bergmann,et al. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. , 1988, Journal of the American College of Cardiology.
[28] M. Schwaiger,et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.
[29] S. Cherry,et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging , 1999, European Journal of Nuclear Medicine.
[30] M Schwaiger,et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] C. Ng,et al. Validation of a model for [1-11C]acetate as a tracer of cardiac oxidative metabolism. , 1994, The American journal of physiology.
[32] G Blomqvist,et al. On the Construction of Functional Maps in Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Simple and Patlak models for myocardial blood flow measurements with nitrogen-13-ammonia and PET in humans. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] R. Gropler,et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. , 1993, Journal of the American College of Cardiology.
[35] D E Kuhl,et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.
[36] M E Phelps,et al. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. , 1989, Circulation.
[37] M. Phelps,et al. A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. , 1991, Journal of the American College of Cardiology.
[38] William H. Press,et al. Numerical Recipes in C, 2nd Edition , 1992 .
[39] S. Bergmann,et al. Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism. , 1993, American heart journal.